220 related articles for article (PubMed ID: 18282643)
21. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
22. Characterization of epithelial cell activity in patients with oral cancer.
Thomson PJ; Potten CS; Appleton DR
Br J Oral Maxillofac Surg; 1999 Oct; 37(5):384-90. PubMed ID: 10577753
[TBL] [Abstract][Full Text] [Related]
23. Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values?
Ahlin C; Aaltonen K; Amini RM; Nevanlinna H; Fjällskog ML; Blomqvist C
Histopathology; 2007 Oct; 51(4):491-8. PubMed ID: 17711446
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical estimation of cell cycle entry and phase distribution in astrocytomas: applications in diagnostic neuropathology.
Scott IS; Morris LS; Rushbrook SM; Bird K; Vowler SL; Burnet NG; Coleman N
Neuropathol Appl Neurobiol; 2005 Oct; 31(5):455-66. PubMed ID: 16150117
[TBL] [Abstract][Full Text] [Related]
25. [Precancer stages of the oral mucosa: a review].
Dunsche A; Härle F
Laryngorhinootologie; 2000 Jul; 79(7):423-7. PubMed ID: 11005096
[TBL] [Abstract][Full Text] [Related]
26. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
Schepman KP; van der Meij EH; Smeele LE; van der Waal I
Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
[TBL] [Abstract][Full Text] [Related]
27. Treatment of oral leukoplakia with carbon dioxide and potassium-titanyl-phosphate lasers: a comparison.
Lim B; Smith A; Chandu A
J Oral Maxillofac Surg; 2010 Mar; 68(3):597-601. PubMed ID: 20171477
[TBL] [Abstract][Full Text] [Related]
28. Management of oral carcinoma: benefits of early precancerous intervention.
Goodson ML; Thomson PJ
Br J Oral Maxillofac Surg; 2011 Mar; 49(2):88-91. PubMed ID: 20678830
[TBL] [Abstract][Full Text] [Related]
29. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.
Kawaguchi H; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim E; Hong WK; Lippman SM; Mao L
J Clin Oncol; 2008 Jan; 26(3):354-60. PubMed ID: 18202409
[TBL] [Abstract][Full Text] [Related]
30. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
[TBL] [Abstract][Full Text] [Related]
31. Cyclin B1 is useful to predict occult cervical lymph node metastases in tongue carcinoma.
Harada H; Omura K; Nakajima Y; Hasegawa S; Mogi S
J Exp Clin Cancer Res; 2006 Sep; 25(3):351-6. PubMed ID: 17167975
[TBL] [Abstract][Full Text] [Related]
32. Progressive derailment of cell cycle regulators in endometrial carcinogenesis.
Horrée N; van Diest PJ; van der Groep P; Sie-Go DM; Heintz AP
J Clin Pathol; 2008 Jan; 61(1):36-42. PubMed ID: 17483252
[TBL] [Abstract][Full Text] [Related]
33. Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication.
Fujioka S; Shomori K; Nishihara K; Yamaga K; Nosaka K; Araki K; Haruki T; Taniguchi Y; Nakamura H; Ito H
Lung Cancer; 2009 Aug; 65(2):223-9. PubMed ID: 19144445
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of anticyclin B1 serum antibody as a diagnostic and prognostic biomarker for lung cancer.
Egloff AM; Weissfeld J; Land SR; Finn OJ
Ann N Y Acad Sci; 2005 Dec; 1062():29-40. PubMed ID: 16461786
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma.
Kushner J; Bradley G; Young B; Jordan RC
J Oral Pathol Med; 1999 Feb; 28(2):77-81. PubMed ID: 9950254
[TBL] [Abstract][Full Text] [Related]
36. Comparison of BrdU and cyclin A as markers of the S-phase in oral precancerous lesions.
Oliver RJ; MacDonald DG
J Oral Pathol Med; 2000 Oct; 29(9):426-31. PubMed ID: 11016684
[TBL] [Abstract][Full Text] [Related]
37. Quantitative analysis of syndecan-1 expression in dysplasia and squamous cell carcinoma of the oral cavity.
Jackson LL; Wade Z; Hessler RB; Abdelsayed R; Rogers JB; Gourin CG
Laryngoscope; 2007 May; 117(5):868-71. PubMed ID: 17473685
[TBL] [Abstract][Full Text] [Related]
38. Colorimetric analysis of unstained lesions surrounding oral squamous cell carcinomas and oral potentially malignant disorders using iodine.
Maeda K; Suzuki T; Ooyama Y; Nakakuki K; Yamashiro M; Okada N; Amagasa T
Int J Oral Maxillofac Surg; 2010 May; 39(5):486-92. PubMed ID: 19963354
[TBL] [Abstract][Full Text] [Related]
39. Postoperative recurrence as an associated factor of malignant transformation of oral dysplastic leukoplakia.
Yang SW; Wu CJ; Lee YS; Chen TA; Tsai CN
ORL J Otorhinolaryngol Relat Spec; 2010; 72(5):280-90. PubMed ID: 20798565
[TBL] [Abstract][Full Text] [Related]
40. Preoperative circulating C-reactive protein levels predict pathological aggressiveness in oral squamous cell carcinoma: a retrospective clinical study.
Chen HH; Chen IH; Liao CT; Wei FC; Lee LY; Huang SF
Clin Otolaryngol; 2011 Apr; 36(2):147-53. PubMed ID: 21332670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
